A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
Cheng N, Watkins-Schulz R, Junkins RD, David CN, Johnson BM, Montgomery SA, Peine KJ, Darr DB, Yuan H, McKinnon KP, Liu Q, Miao L, Huang L, Bachelder EM, Ainslie KM, Ting JP.
Cheng N, et al.
JCI Insight. 2018 Nov 15;3(22):e120638. doi: 10.1172/jci.insight.120638.
JCI Insight. 2018.
PMID: 30429378
Free PMC article.